Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults? (Q35877689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

main subject

anti-retroviral agent

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

H McManus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

P C K Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

D Nolan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Bloch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

S Kiertiburanakul

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

B Mulhall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

K Petoumenos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

J Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

M Law

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

E Wright

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

7 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

610-619

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

9 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

The TREAT Asia HIV Observational Database: baseline and retrospective data

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Determinants of survival in HIV-positive patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00938.X

Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00938.X

Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00938.X

Mild cognitive impairment and risk of mortality in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00938.X

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

HIV, the brain, children, HAART and 'neuro-HAART': a complex mix.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL

24 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00938.X

Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322175

Rates of combination antiretroviral treatment change in Australia, 1997-2000

14 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21819527

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1468-1293.2011.00938.X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PubMed publication ID

21819527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21819527%20AND%20SRC:MED&resulttype=core&format=json